Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-23-001186
Filing Date
2023-01-18
Accepted
2023-01-18 16:49:04
Documents
4
Effectiveness Date
2023-01-18

Document Format Files

Seq Description Document Type Size
1 S-8 forms-82023.htm S-8 51606
2 EX-FILING FEES s-8xexhibit107.htm EX-FILING FEES 14395
3 EX-5.1 s-8xexhibit51.htm EX-5.1 8515
4 EX-23.1 s-8xexhibit231.htm EX-23.1 2020
  Complete submission text file 0001628280-23-001186.txt   77594
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269292 | Film No.: 23534945
SIC: 2834 Pharmaceutical Preparations